[Remodeling myocardium and skeletal muscle in chronic heart failure]

Insights

Chronic heart failure (CHF) causes similar tissue and cellular changes in both the heart muscle (myocardium) and skeletal muscles. These changes worsen as CHF progresses, indicating a systemic effect beyond the heart.

Area of Science:

  • Cardiovascular Biology
  • Skeletal Muscle Physiology
  • Pathology

Context:

  • Chronic heart failure (CHF) is traditionally studied via myocardial and peripheral vessel remodeling.
  • The adaptive role of remodeling in skeletal muscle during CHF remains unclear.
  • Investigating shared morphological changes is crucial for understanding CHF progression.

Purpose:

  • To investigate morphological changes in the myocardium and skeletal muscle in CHF patients.
  • To examine the interrelations between myocardial and skeletal muscle conditions in CHF.
  • To compare tissue, cellular, and subcellular changes in both muscle types.

Summary:

  • Morphological changes in the myocardium and skeletal muscle are similar across tissue, cellular, and subcellular levels in CHF patients.
  • Hypertrophy and fiber heteromorphism increase in both muscle types as CHF severity (NYHA class) advances.
  • A significant correlation (r = 0.57, p < 0.05) exists between the cellular-stromal ratio changes in the myocardium and skeletal muscle.

Impact:

  • Findings suggest CHF involves systemic skeletal muscle pathology, not just cardiac remodeling.
  • Highlights the potential for shared therapeutic targets for both cardiac and skeletal muscle dysfunction in CHF.
  • Provides novel insights into the pathophysiology of chronic heart failure and its systemic impact.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...